(Q36468107)

14 August 2017

1 reference

17 November 2019

Treatment of breast cancer with aromatase inhibitors--current status and future prospects (English)

1 reference

14 August 2017

1 reference

17 November 2019

1 reference

17 November 2019

1

Lønning PE

1 reference

14 August 2017

Dowsett M

2

1 reference

PMCID

2247352

14 August 2017

Powles TJ

series ordinal

3

1 reference

PMCID

2247352

14 August 2017

language of work or name

English

0 references

publication date

1 July 1989

6 references

British Journal of Cancer

14 August 2017

13 March 2019

3 April 2019

17 June 2019

2 October 2019

17 November 2019

6 references

14 August 2017

13 March 2019

3 April 2019

17 June 2019

2 October 2019

17 November 2019

60

1 reference

14 August 2017

1

1 reference

14 August 2017

5-8

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1989.208

14 August 2017

0 references

cites work

Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247352

Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247352

Aminoglutethimide in advanced breast cancer: clinical results of a French multicenter randomized trial comparing 500 mg and 1 g/day

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247352

Aromatase activity in adipose tissue from breast quadrants: a link with tumour site.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247352

Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247352

Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247352

A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247352

Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247352

The Hormonal Activity of the Postmenopausal Ovary

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247352

Adrenal Suppression with Aminoglutethimide. III. Comparison of Plasma Δ4- and Δ5-Steroids in Postmenopausal Women Treated for Breast Carcinoma*

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247352

A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247352

Effects of aminoglutethimide on adrenal steroid secretion

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247352

Source of Estrogen Production in Postmenopausal Women1

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247352

Inhibition of adrenal corticosteroid synthesis by aminoglutethimide: studies of the mechanism of action.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247352

Endogenous steroid concentrations in human breast tumours determined by high-resolution mass fragmentography

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247352

Analogues of aminoglutethimide: selective inhibition of aromatase

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247352

Aminoglutethimide without hydrocortisone in the treatment of postmenopausal patients with advanced breast cancer.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247352

Estrone and estradiol content in human breast tumors: Relationship to estradiol receptors

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247352

Inhibition of Peripheral Aromatization of Androstenedione to Estrone in Postmenopausal Women with Breast Cancer Using Δ1Testololactone*

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247352

Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247352

Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247352

Effects of amino-glutethimide on adrenal function in man.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247352

A comparative evaluation of adrenalectomy and cortisone in the treatment of advanced mammary carcinoma

21 September 2018

1 reference

12 December 2020

Aminoglutethimide Inhibition of Adrenal Desmolase Activity

1 reference

12 December 2020

Hypophysectomy as compared with adrenalectomy in the treatment of advanced carcinoma of the breast

1 reference

12 December 2020

The involvement of human placental microsomal cytochrome P-450 in aromatization

1 reference

12 December 2020

Successful medical adrenalectomy with amino-glutethimide. Role of altered drug metabolism

1 reference

12 December 2020

Medical and surgical adrenalectomy in patients with advanced breast carcinoma

1 reference

12 December 2020

Adrenal suppression with aminoglutethimide. II. Differential effects of aminoglutethimide on plasma androstenedione and estrogen levels

1 reference

12 December 2020

Androgen-estrogen production rates in postmenopausal women with breast cancer

1 reference

12 December 2020

Endogenous oestradiol-17β concentration in breast tumours determined by mass fragmentography and by radioimmunoassay: Relationship to receptor content

1 reference

12 December 2020

In vivo and in vitro pharmacological studies of aminoglutethimide as an aromatase inhibitor

1 reference

12 December 2020

Randomized trial of aminoglutethimide versus tamoxifen in metastatic breast cancer

1 reference

12 December 2020

Cross-over comparison of tamoxifen and aminoglutethimide in advanced breast cancer

1 reference

12 December 2020

A comparison of the in vivo uptake and metabolism of 3H-oestrone and 3H-oestradiol by normal breast and breast tumour tissues in post-menopausal women

1 reference

12 December 2020

Aromatase activity in primary and metastatic human breast cancer

1 reference

12 December 2020

Estrogen production and metabolism in normal postmenopausal women and postmenopausal women with breast or endometrial cancer

1 reference

12 December 2020

Oral 4-hydroxyandrostenedione, a new endocrine treatment for disseminated breast cancer

1 reference

12 December 2020

CGS 16949A, a new nonsteroidal aromatase inhibitor: effects on hormone-dependent and -independent tumors in vivo

1 reference

12 December 2020

Alterations in the metabolism of oestrogens during treatment with aminoglutethimide in breast cancer patients. Preliminary findings

1 reference

12 December 2020

Suppression of postmenopausal ovarian steroidogenesis with the luteinizing hormone-releasing hormone agonist goserelin

1 reference

12 December 2020

[Hypophysectomy in man.]

1 reference

12 December 2020

Adrenalectomy and oophorectomy in treatment of advanced carcinoma of the breast

1 reference

12 December 2020

The use of prednisolone in the treatment of disseminated breast carcinoma

1 reference

12 December 2020

Hormonal therapy in cancer of the breast 16. The effect of Delta 1-testololactone on clinical course and hormonal excretion

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1989.208

1 reference

14 August 2017

1 reference

14 August 2017

1 reference

PMCID

2247352